Amneal Pharmaceuticals, Inc. Stock News

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company"), one of the largest U.S.-based generics manufacturers, today announced that it is responding to the national COVID-19 health emerg

Bellerophon Therapeutics (NASDAQ:BLPH) +472% on FDA nod for emergency use of INOpulse for Covid-19.Rand Capital (NASDAQ:RAND) +87% on its portfolio company developing automated test kits for detection

Amneal Pharmaceuticals, Inc. (AMRX) is now among the bigger bargains in its industry. Within the last year the price ranged from $2.27 – 14.65 and there is a wide opportunity to get in. Its next ear

Mylan N.V. (MYL +6%) has restarted production of hydroxychloroquine sulfate tablets at its West Virginia facility in order to meet COVID-19-related demand, although it is not formerly approved for thi

Prudential Financial Inc. lessened its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange

Amneal Pharmaceuticals Inc (NYSE:AMRX) has received an average recommendation of “Hold” from the thirteen analysts that are currently covering the stock, Marketbeat reports. Two analysts have rate

Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chintu Patel acquired 100,000 shares of the business’s stock in a transaction dated Tuesday, March 10th. The shares were bought at an average price of $3.0

Amneal Pharmaceuticals Inc (NYSE:AMRX) Director Gautam Patel bought 32,111 shares of Amneal Pharmaceuticals stock in a transaction on Monday, March 2nd. The stock was acquired at an average cost of $3

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte

Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chirag K. Patel bought 34,641 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was purchased at an average cost of $3.87 per

Amneal Pharmaceuticals Inc:

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has appointed Tasos Konidaris as Senior Vice President, Chief Financial Officer, effective March 12, 2020. Mr.

Amneal Pharmaceuticals Inc (NYSE:AMRX) CEO Chirag K. Patel bought 58,938 shares of Amneal Pharmaceuticals stock in a transaction dated Wednesday, March 4th. The shares were bought at an average cost o

Brokerages predict that Amneal Pharmaceuticals Inc (NYSE:AMRX) will post $435.77 million in sales for the current quarter, according to Zacks. Five analysts have provided estimates for Amneal Pharmace

Rhumbline Advisers lifted its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 13.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 147,019 shares of the company’